Cancer
Researchers at King Abdulaziz University, led by Ahdab A. Alsaieedi and Kawther A. Zaher, have been instrumental in advancing the field of cancer immunotherapy, particularly in the realm of Chimeric Antigen Receptor (CAR)-T cell therapy. This innovative approach harnesses the adaptive immune system to selectively target and eradicate cancer
Cancer
Researchers at the University of California, Los Angeles (UCLA), have made a significant discovery in the field of cancer treatment. A new study has demonstrated the effectiveness of tandem cell therapies involving autologous T cells and hematopoietic stem cells engineered to express the NY-ESO-1 TCR for the treatment of solid
Cancer
Researchers from Sichuan University have proposed an innovative nanocomposite hydrogel system for the co-delivery of cisplatin and short hairpin RNA (shRNA) targeting protein arginine methyltransferase 5 (PRMT5), a key gene implicated in drug resistance. This system utilizes polyethyleneimine-modified mesoporous silica nanoparticles, which serve as nanocarriers, encapsulating cisplatin within the mesopores
Cancer
Researchers at the Chinese Academy of Sciences in Hefei, People's Republic of China, have made a significant breakthrough in cancer detection using pan-cancer technology. This innovative approach enables simultaneous screening for multiple cancer types, improving cure and survival rates. Funded by the Hefei Cancer Hospital and the Chinese
Cancer
A new study published in the journal Cancers has analyzed the demographic and clinical characteristics of kidney cancer patients during the pre-COVID-19 and COVID-19 periods. The research, conducted at the University of Pecs, Hungary, found significant changes in the detection of kidney cancer, including a decline in incidental tumor detection
Cancer
A new study published in Frontiers in Nutrition has highlighted the potential of probiotic-derived postbiotics as a sustainable and effective alternative to live microbial therapy in cancer gene therapy. Research from the School of Biosciences and Technology in Vellore, India, has shown that postbiotics, bioactive metabolites produced by probiotics, possess
Cancer
A study published in the journal Vascular has explored the impact of preoperative disseminated cancer on the 30-day outcomes of endovascular aneurysm repair (EVAR) for non-ruptured abdominal aortic aneurysms (AAAs). Researchers from George Washington University analyzed data from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database
Cancer
Oncologists in China are cautiously embracing the potential benefits of artificial intelligence (AI)-driven chatbots in cancer patient education, but numerous concerns about liability, misinformation, and data security risks are hindering wider adoption. A recent study involving 24 oncologists from four hospitals in Southwest and East China found that while
Cancer
Researchers from JSS College of Pharmacy have made significant strides in the development of microneedle-based delivery systems for targeted cancer therapy. These minimally invasive systems have the potential to overcome the limitations of conventional drug delivery methods, enabling direct delivery of chemotherapeutic agents to tumor sites and reducing systemic toxicity.
Cancer
Dr. Rubul Mout, a research fellow at Harvard Medical School and Boston Children's Hospital, has led a groundbreaking scientific team that has developed AI-designed synthetic proteins capable of significantly enhancing cancer immunotherapy. This innovation utilizes the Notch signalling pathway to produce large-scale T-cells in simpler, suspension-based environments, making
Cancer
A recently published multicenter clinical study confirms the exceptional diagnostic performance of the Destinex assay, a novel liquid biopsy, for the early detection of gastric cancer. The study, led by Ajay Goel, Ph.D., found that the assay achieved an area under the curve (AUC) of 96.8% in the
Cancer
Recent research published in Nature Communications has shed light on the epigenetic programs essential for platelet biogenesis. The study, conducted at the University of Texas MD Anderson Cancer Center, focused on the roles of histone lysine methyltransferases MLL3 and MLL4 in regulating gene expression during platelet production. The findings suggest
